Financial Perspectives, Inc Plus Therapeutics, Inc. Transaction History

Financial Perspectives, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jan 09, 2024	SELL	$0.23 - $4.91 $0 - $4	-1 Closed	0 $0
Q2 2021 Jan 09, 2024	SELL	$2.0 - $2.89 $2 - $2	-1 Reduced 50.0%	1 $3,000
Q1 2021 Jan 09, 2024	BUY	$2.1 - $3.75 $2 - $3	1 Added 100.0%	2 $1,000
Q4 2019 Jan 09, 2024	BUY	$1.99 - $3.23 $1 - $3	1 New	1 $2,000

Ticker PSTV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,601,400
Market Cap $51.4M
Description
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, lep...

Get notified when there are updates to the investment portfolio of Financial Perspectives, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Perspectives, Inc with notifications on news.